{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:46:15Z","timestamp":1777589175092,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.cyto.2016.06.004","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T22:47:39Z","timestamp":1465426059000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Circulating lipocalin 2 is neither related to liver steatosis in patients with non-alcoholic fatty liver disease nor to residual liver function in cirrhosis"],"prefix":"10.1016","volume":"85","author":[{"given":"Elisabeth M.","family":"Meier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekka","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Rein-Fischboeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Schacherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Eisinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Krautbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-3994","authenticated-orcid":false,"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.06.004_b0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2016.06.004_b0010","first-page":"2801","article-title":"Adiponectin, a key adipokine in obesity related liver diseases","volume":"17","author":"Buechler","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cyto.2016.06.004_b0015","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/ijc.28105","article-title":"Obesity, adipokines and hepatocellular carcinoma","volume":"133","author":"Duan","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cyto.2016.06.004_b0020","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.2174\/092986712803833254","article-title":"Adiponectin: key player in the adipose tissue-liver crosstalk","volume":"19","author":"Moschen","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cyto.2016.06.004_b0025","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2337\/db08-1750","article-title":"Systemic fate of the adipocyte-derived factor adiponectin","volume":"58","author":"Halberg","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.cyto.2016.06.004_b0030","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1159\/000368474","article-title":"Diagnostic and prognostic utility of neutrophil gelatinase-associated lipocalin (NGAL) in patients with cardiovascular diseases \u2013 review","volume":"39","author":"Helanova","year":"2014","journal-title":"Kidney Blood Pressure Res."},{"key":"10.1016\/j.cyto.2016.06.004_b0035","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1210\/me.2007-0420","article-title":"The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages","volume":"22","author":"Zhang","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.cyto.2016.06.004_b0040","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.bbalip.2014.07.017","article-title":"Lipocalin-2 (LCN2) regulates PLIN5 expression and intracellular lipid droplet formation in the liver","volume":"1842","author":"Asimakopoulou","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cyto.2016.06.004_b0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0032-1331696","article-title":"Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease","volume":"121","author":"Auguet","year":"2013","journal-title":"Exp. Clin. Endocrinol. Diabetes: Official J., German Soc. Endocrinol. German Diabetes Assoc."},{"key":"10.1016\/j.cyto.2016.06.004_b0050","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/00365521.2013.836754","article-title":"Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease","volume":"49","author":"Suh","year":"2014","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.cyto.2016.06.004_b0055","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s11033-013-2977-5","article-title":"Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease","volume":"41","author":"Ye","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.cyto.2016.06.004_b0060","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbadis.2013.01.014","article-title":"Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis","volume":"1832","author":"Borkham-Kamphorst","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cyto.2016.06.004_b0065","doi-asserted-by":"crossref","first-page":"16443","DOI":"10.3748\/wjg.v20.i44.16443","article-title":"Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease","volume":"20","author":"Ceccarelli","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2016.06.004_b0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jgh.12019","article-title":"Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis","volume":"28","author":"Roh","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2016.06.004_b0075","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.4049\/jimmunol.1200892","article-title":"Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis","volume":"189","author":"Srinivasan","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.06.004_b0080","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1097-2765(02)00708-6","article-title":"The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition","volume":"10","author":"Goetz","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cyto.2016.06.004_b0085","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1478-3231.2011.02495.x","article-title":"Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1beta through nuclear factor-kappaB activation","volume":"31","author":"Borkham-Kamphorst","year":"2011","journal-title":"Liver Int.: Official J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.cyto.2016.06.004_b0090","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2016.06.004_b0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J. Hepatol."},{"issue":"Spec Issue","key":"10.1016\/j.cyto.2016.06.004_b0100","first-page":"15","article-title":"Neutrophil Gelatinase Associated Lipocalin (NGAL) \u2013 a biomarker of renal dysfunction in patients with liver cirrhosis: do we have enough proof?","volume":"8","author":"Firu","year":"2015","journal-title":"J. Med. Life"},{"key":"10.1016\/j.cyto.2016.06.004_b0105","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.yexmp.2011.07.005","article-title":"Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro","volume":"91","author":"Bauer","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.cyto.2016.06.004_b0110","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.2009.193227","article-title":"TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update","volume":"59","author":"Rossle","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2016.06.004_b0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.regpep.2012.08.007","article-title":"Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injury","volume":"179","author":"Bauer","year":"2012","journal-title":"Regul. Pept."},{"key":"10.1016\/j.cyto.2016.06.004_b0120","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/eci.12122","article-title":"Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension","volume":"43","author":"Eisinger","year":"2013","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.cyto.2016.06.004_b0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.yexmp.2015.01.010","article-title":"Reduced serum chemerin in patients with more severe liver cirrhosis","volume":"98","author":"Eisinger","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.cyto.2016.06.004_b0130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cyto.2011.06.001","article-title":"Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function","volume":"55","author":"Wanninger","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2016.06.004_b0135","doi-asserted-by":"crossref","first-page":"E499","DOI":"10.1111\/hepr.12327","article-title":"Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: proceed with caution","volume":"44","author":"Yoneda","year":"2014","journal-title":"Hepatol. Res.: Official J. Jpn. Soc. Hepatol."},{"key":"10.1016\/j.cyto.2016.06.004_b0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/1573399810602040449","article-title":"Physiological significance of resistin and resistin-like molecules in the inflammatory process and insulin resistance","volume":"2","author":"Asano","year":"2006","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.cyto.2016.06.004_b0145","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.tem.2010.08.001","article-title":"Chemerin: at the crossroads of inflammation and obesity","volume":"21","author":"Ernst","year":"2010","journal-title":"Trends Endocrinol. Metabolism: TEM"},{"key":"10.1016\/j.cyto.2016.06.004_b0150","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.metabol.2009.09.011","article-title":"Splanchnic concentrations and postprandial release of visceral adipokines","volume":"59","author":"Wiest","year":"2010","journal-title":"Metab., Clin. Exp."},{"key":"10.1016\/j.cyto.2016.06.004_b0155","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s10620-006-9310-2","article-title":"Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child\u2019s status","volume":"51","author":"Wadhawan","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cyto.2016.06.004_b0160","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/hep.22896","article-title":"Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease","volume":"49","author":"Milner","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2016.06.004_b0165","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2265.2008.03374.x","article-title":"Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women","volume":"70","author":"Choi","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cyto.2016.06.004_b0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1440-1797.2007.00899.x","article-title":"Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease","volume":"13","author":"Malyszko","year":"2008","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.cyto.2016.06.004_b0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-2008-1062746","article-title":"Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA","volume":"40","author":"Stejskal","year":"2008","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cyto.2016.06.004_b0180","first-page":"2853","article-title":"Lipocalin-2 plasmatic levels are reduced in patients with long-term type 2 diabetes mellitus","volume":"8","author":"De la Chesnaye","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.cyto.2016.06.004_b0185","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/oby.2011.61","article-title":"Upregulation of lipocalin 2 in adipose tissues of severely obese women: positive relationship with proinflammatory cytokines","volume":"19","author":"Auguet","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.cyto.2016.06.004_b0190","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.clinbiochem.2014.03.017","article-title":"Plasma neutrophil gelatinase-associated lipocalin levels are markedly increased in patients with non-transfusion-dependent thalassemia: lack of association with markers of erythropoiesis, iron metabolism and renal function","volume":"47","author":"Patsaoura","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cyto.2016.06.004_b0195","first-page":"113","article-title":"C-reactive protein and bacterial infection in cirrhosis","volume":"27","author":"Pieri","year":"2014","journal-title":"Ann. Gastroenterol.: Q. Publ. Hellenic Soc. Gastroenterol."},{"key":"10.1016\/j.cyto.2016.06.004_b0200","article-title":"Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease","author":"Wieser","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2016.06.004_b0205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2014.07.043","article-title":"Resistin: insulin resistance to malignancy","volume":"438","author":"Codoner-Franch","year":"2015","journal-title":"Clin. Chim. Acta"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1043466616301338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1043466616301338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T11:59:44Z","timestamp":1498305584000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616301338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":41,"alternative-id":["S1043466616301338"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.06.004","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating lipocalin 2 is neither related to liver steatosis in patients with non-alcoholic fatty liver disease nor to residual liver function in cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.cyto.2016.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}